Rosenstein, B.S.B.S.RosensteinWest, C.M.C.M.WestBentzen, Sø.M.Sø.M.BentzenAlsner, J.J.AlsnerAndreassen, C.N.C.N.AndreassenAzria, D.D.AzriaBarnett, G.C.G.C.BarnettBaumann, M.M.BaumannBurnet, N.N.BurnetChang-Claude, J.J.Chang-ClaudeERIC YAO-YU CHUANGColes, C.E.C.E.ColesDekker, A.A.DekkerDe Ruyck, K.K.De RuyckDe Ruysscher, D.D.De RuysscherDrumea, K.K.DrumeaDunning, A.M.A.M.DunningEaston, D.D.EastonEeles, R.R.EelesFachal, L.L.FachalGutiérrez-Enríquez, S.S.Gutiérrez-EnríquezHaustermans, K.K.HaustermansHenríquez-Hernández, L.A.L.A.Henríquez-HernándezImai, T.T.ImaiJones, G.D.D.G.D.D.JonesKerns, S.L.S.L.KernsLiao, Z.Z.LiaoOnel, K.K.OnelOstrer, H.H.OstrerParliament, M.M.ParliamentPharoah, P.D.P.P.D.P.PharoahRebbeck, T.R.T.R.RebbeckTalbot, C.J.C.J.TalbotThierens, H.H.ThierensVega, A.A.VegaWitte, J.S.J.S.WitteWong, P.P.WongZenhausern, F.F.Zenhausern2020-04-162020-04-162014https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903188157&doi=10.1016%2fj.ijrobp.2014.03.009&partnerID=40&md5=002bc84ff8bb18bcace5879fdaa7a5da[SDGs]SDG3biological marker; biotechnology; cancer epidemiology; cancer patient; cancer radiotherapy; cancer screening; cancer susceptibility; clinical research; disease predisposition; editorial; effect size; eradication therapy; gene frequency; genetic association; genetic variability; genomics; Hodgkin disease; human; medical informatics; molecular biology; national health organization; priority journal; prostate cancer; quality of life; radiation hazard; radiation injury; radiation oncologist; radiation response; radiobiology; radiogenomics; radiology; risk factor; sample size; science; single nucleotide polymorphism; Alleles; Chromosome Aberrations; Genetic Predisposition to Disease; Genome-Wide Association Study; Genomics; Genotype; Humans; Neoplasms; Phenotype; Polymorphism, Single Nucleotide; Radiation Injuries; Radiation Tolerance; Radiotherapy Dosage; Sample Sizeother10.1016/j.ijrobp.2014.03.0092-s2.0-84903188157